Neolytica Experiences Explosive Business Growth
Morristown, NJ – March 17, 2022 – Neolytica, a healthcare analytics firm, today announced that it has experienced explosive business growth over the past year. The company has added numerous enterprise-level customers to its roster, and now counts 12 of the top 20 pharmaceutical companies among its clients.
Neolytica’s growth is due to its unique approach to healthcare analytics, which combines data science and artificial intelligence to help life sciences companies improve their medical communication and commercialization activities. The company’s tools include:
1. Ti Expert®, which provides comprehensive data about Key Opinion Leaders, Community Opinion Leaders, and their promotional activities and spheres of influence;
2. NotifyMe®, which enables real-time, enterprise-scale monitoring of KOL social activities; and
3. Ti Risk®, which identifies prescribers and patients who may be involved in the diversion of opioids.
Neolytica is a subsidiary of QPharma, a longtime industry leader in commercial and compliance products and services. With the exponential growth of Neolytica, QPharma has been able to fill a previously unbridged gap in the industry by creating a single platform that can be leveraged by Medical, Marketing, and Commercial teams.
“We are thrilled with the growth that Neolytica has experienced over the past year,” said Badal Shah, B.Pharmacy, MBS, who established Neolytica and serves as its Managing Director. “Our unique approach to healthcare analytics is resonating with life sciences companies, and we are excited to continue to help them improve their medical communication and commercialization activities.”
Neolytica is continuing to grow and innovate. The company is adding new artificial intelligence tools to its platforms, including chat bots that you can query for real-time information, as well as enhanced Digital Opinion Leader module and eventually Medical CRM.
“We are committed to providing the most innovative and comprehensive healthcare analytics solutions to our clients,” said Shah. “We believe that our continued growth and innovation will help us to become the leading provider of healthcare analytics solutions in the world.”
About Neolytica
Neolytica is a healthcare analytics firm that provides data science and artificial intelligence solutions to life sciences companies. The company’s solutions help life sciences companies improve their medical communication and commercialization activities. Neolytica is a subsidiary of QPharma, a longtime industry leader in commercial and compliance products and services.
About QPharma
Founded in 1994, QPharma is the industry leader in cloud-based software and services for life sciences. The Commercial Services division provides solutions that include sample management and distribution, product launch management, online training, and HCP/KOL targeting and engagement. Services offered by the company’s Professional Services division include validation services, project management, auditing, and training. QPharma is a National Association of Boards of Pharmacy Verified.
